TrialCytotherapy2020

Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemia.

Rajeswaran Mani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.